The first implantation of the VasQ external support device was performed in Greece, Laminate Medical Technologies announced in a press release. The procedure was successfully performed by Alexandros Mallios (Henry Dunant Hospital Center, Athens, Greece).
Sharing his thoughts on the procedure, Mallios stated that “international collaboration between care providers and industry partners is key for raising the standard of care in vascular access with innovations like VasQ for end-stage renal disease patients, not just in Greece, but around the world”.
VasQ, the press release states, is a ground-breaking technology designed to improve surgical fistula outcomes from the point of creation. Laminate also reports that it is the only device of its kind that is designed and marketed to do so. As well as this, it also feels that the device is unique in that it is implanted around the artery-vein connection to provide permanent external support to the mobilised venous segment, which is the typical site of early fistula failure. It provides this support by reinforcing the vessels against excessive wall tension and promoting a more stable flow profile compared to unsupported fistulas.
“We take pride in introducing Laminate’s cutting-edge technology to more regions around the world,” said Tammy Gilon, Laminate chief executive officer, “and are happy to serve the end-stage renal disease community in Greece. We eagerly anticipate extending the benefits of VasQ globally.”
